← Back

LionBio Therapeutics

United States

pre-seed$6M raisedFreshly fundedBiotech

◆ Total Raised

$6M

◆ Stage

pre-seed

◆ Location

United States

◆ Links

◆ About LionBio Therapeutics

Biotech startup developing nanoparticle-encapsulated nasal GLP-1 delivery technology, starting with intranasal semaglutide.

◆ Sectors

Biotech

◆ Funding rounds

7 Nov 2026

Led by South Park Commons

Source ↗

◆ Explore the market

◆ FAQ

What does LionBio Therapeutics do?

Biotech startup developing nanoparticle-encapsulated nasal GLP-1 delivery technology, starting with intranasal semaglutide.

Where is LionBio Therapeutics based?

LionBio Therapeutics is based in United States.

How much has LionBio Therapeutics raised?

LionBio Therapeutics has raised $6M in tracked funding and is currently at the pre-seed stage.